CD274 and neoplasm: Pretreatment biopsy specimens from 60 patients treated with anti-PD-1 or PD-L1 antibodies underwent tumor sequencing by the MSK_IMPACT assay and the presence of DDR alterations was correlated with clinical outcomes.